Medication Overuse Headache

Medication Overuse Headache Publisher

Mohammadianinejad SE¹ ; Ansari B²

Show Affiliations

1. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Isfahan University of Medical Science, Isfahan, Iran

Source: Headache and Migraine in Practice Published:2022

Abstract

Medication overuse headache (MOH) is a secondary headache disorder in the form of a chronic daily headache resulting from analgesic overuse for the course of 10-15 days per month, depending on the type of analgesic, in a patient with preexisting frequent migraine or, less often, tension-type headache (TTH). It mainly presents as the more frequent occurrence of previous headaches with a tendency to show fewer migraine features due to the effect of the analgesics. Specific demographic features and the presence of comorbidities and lifestyle features and habits are risk factors for development of MOH in an individual with frequent migraine or TTH. A multidisciplinary approach that includes stopping analgesic use, managing lifestyle and habits, and pharmacologic therapy can help the patient to overcome this particularly disabling condition. © 2022 Elsevier Inc. All rights reserved.

Related Docs

View other Related Docs

1. Effects of Greater Occipital Nerve Block With Local Anesthetic and Triamcinolone for Treatment of Medication Overuse Headache: An Open-Label, Parallel, Randomized, Controlled Clinical Trial, Neurological Sciences (2022)

2. Is There a Relationship Between 24-Hour Urinary Sodium and Potassium and Mental Health in Migraine Patients?: A Cross-Sectional Study, Medicine (United States) (2022)

3. Epidemiologic and Clinical Characteristics of Migraine Headaches: A Descriptive Study in Isfahan, Iran, Journal of Isfahan Medical School (2012)

4. The Effect of Psychosocial Group-Therapy on Improvement of Migraine Attacks and Quality of Life of Patients With Migraine, Journal of Isfahan Medical School (2015)

5. Reliability and Validity of the Persian Hit-6 Questionnaire in Migraine and Tension-Type Headache, Pain Practice (2014)

6. New Daily Persistent Headache (Ndph): Unraveling the Complexities of Diagnosis, Pathophysiology, and Treatment, Current Pain and Headache Reports (2023)

7. Longitudinal Modeling of Non-Pharmacological Factors Related to Frequency, Severity and Duration in Both Migraine and Tension-Type Headaches, Journal of Research in Health Sciences (2020)

8. Comparing the Effects of Memantine and Sodium Valproate in Prevention of Chronic and Episodic Migraine, Journal of Isfahan Medical School (2015)

Experts (# of related papers)

View all Related Experts

Fariborz Khorvash (5)

Gholamreza Askari (5)

Style	Citing Format
MLA	Mohammadianinejad SE, Ansari B. "Medication Overuse Headache." Headache and Migraine in Practice, vol. , no. , 2022, pp. 161-168.
APA	Mohammadianinejad SE, Ansari B (2022). Medication Overuse Headache. Headache and Migraine in Practice, (), 161-168.
Chicago	Mohammadianinejad SE, Ansari B. "Medication Overuse Headache." Headache and Migraine in Practice , no. (2022): 161-168.
Harvard	Mohammadianinejad SE, Ansari B (2022) 'Medication Overuse Headache', Headache and Migraine in Practice, (), pp. 161-168.
Vancouver	Mohammadianinejad SE, Ansari B. Medication Overuse Headache. Headache and Migraine in Practice. 2022;():161-168.
BibTex	@article{ author = {Mohammadianinejad SE and Ansari B}, title = {Medication Overuse Headache}, journal = {Headache and Migraine in Practice}, volume = {}, number = {}, pages = {161-168}, year = {2022} }
RIS	TY - JOUR AU - Mohammadianinejad SE AU - Ansari B TI - Medication Overuse Headache JO - Headache and Migraine in Practice VL - IS - SP - 161 EP - 168 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract